Biomarkers of mitochondrial dysfunction and inflammaging in older adults and blood pressure variability

S. Lehéricy | M. Chupin | J. Dartigues | J. Darcourt | M. Zanca | K. Bennys | J. Touchon | M. Allard | C. Dufouil | P. Livet | P. Payoux | S. Belleville | S. Andrieu | S. Chanalet | Y. Rolland | B. Vellas | N. Coley | S. Guyonnet | I. Carrié | L. Brigitte | C. Faisant | F. Lala | J. Delrieu | H. Villars | Emeline Combrouze | Carole Badufle | A. Zueras | C. Cantet | Christophe Morin | C. Dupuy | C. Caillaud | P. Ousset | S. Willis | B. Gilbert | F. Fontaine | Isabelle Marcet | F. Delva | Sandrine Cerda | Marie-Noëlle-Cuffi | Corinne Costes | O. Rouaud | P. Manckoundia | V. Quipourt | S. Marilier | Evelyne Franon | L. Bories | Marie-Laure Pader | Marie-France Basset | Bruno Lapoujade | V. Faure | Michael Li Yung Tong | C. Malick-Loiseau | Evelyne Cazaban-Campistron | F. Desclaux | Colette Blatge | T. Dantoine | C. Laubarie-Mouret | I. Saulnier | J. Clément | M. Picat | S. Willebois | I. Desormais | M. Bonnefoy | P. Rebaudet | Claire Gédéon | Catherine Burdet | Flavien Terracol | Stephanie Roth | S. Chaillou | S. Louchart | K. Sudres | N. Lebrun | Nadège Barro-Belaygues | A. Gabelle | Lynda Touati | C. Marelli | Cécile Pays | C. Gervais | S. Gonfrier | Y. Gasnier | S. Bordes | Danièle Begorre | Christian Carpuat | Khaled Khales | Jean-François Lefebvre | Samira Misbah El Idrissi | Pierre Skolil | J. Salles | Ali Bouhayia | F. Ricolfi | M. Martel | F. Cotton | A. Bonafe | Françoise Hugon | F. Bonneville | C. Cognard | François Chollet | Sophie Peiffer | A. Hitzel | L. Molinier | H. Derumeaux | C. Vinel | P. de Souto Barreto | S. Caspar-Bauguil | T. Voisin | A. Parini | G. A. van Kan | F. Le Duff | J. F. Mangin | P. Cestac | L. Rouch | Alexandre Lucas | Bruno Sophie Isabelle Lauréane Catherine Françoise Julie Vellas Guyonnet Carrié Brigitte Faisant Lal | Alexandra Foubert | Alain Pesce | Philippe Robert | Dominique Dubois | Jacques Monteil | L. Bencivenga | N. Costa | A. Pesce | P. Olivier‐Abbal | Mathilde Strumia | L. Martinez | L. Bernard‐Bourzeix | N. Cardinaud | A. Romano | B. Perret | M. Strumia | P. Robert | Claire Vinel | Valérie Faure | Stéphanie Willebois | Pascale Rebaudet | Bruno Vellas | Sandrine Andrieu | Yves Rolland

[1]  O. Hanon,et al.  Blood pressure variability: A potential marker of aging , 2022, Ageing Research Reviews.

[2]  C. Giuliani,et al.  GDF15, an emerging key player in human aging , 2022, Ageing Research Reviews.

[3]  D. Shin,et al.  Blood pressure variability and the risk of fracture: a nationwide cohort study. , 2021, The Journal of clinical endocrinology and metabolism.

[4]  G. Fuellen,et al.  Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring , 2021, Frontiers in Genetics.

[5]  A. Hofman,et al.  Visit-to-Visit Blood Pressure Variability, Neuropathology, and Cognitive Decline , 2021, Neurology.

[6]  O. Hanon,et al.  Visit-to-visit blood pressure variability and incident frailty in older adults. , 2021, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  Y. Rolland,et al.  Cross-sectional associations between cortical thickness and physical activity in older adults with spontaneous memory complaints: The MAPT Study , 2021, Journal of sport and health science.

[8]  Myung-Shik Lee,et al.  GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH. , 2020, Biochimica et biophysica acta. General subjects.

[9]  C. Reid,et al.  Long-Term Blood Pressure Variability and Risk of Cardiovascular Disease Events Among Community-Dwelling Elderly , 2020, Hypertension.

[10]  F. Pasquier,et al.  Visit-to-Visit Blood Pressure Variability Is Associated With Cognitive Decline and Incident Dementia , 2020, Hypertension.

[11]  C. Franceschi,et al.  Inflammaging, hormesis and the rationale for anti-aging strategies , 2020, Ageing Research Reviews.

[12]  Ludger J. E. Goeminne,et al.  Growth differentiation factor 15 protects against the aging‐mediated systemic inflammatory response in humans and mice , 2020, Aging cell.

[13]  K. Yaffe,et al.  Systolic blood pressure postural changes variability is associated with greater dementia risk , 2020, Neurology.

[14]  C. Franceschi,et al.  GDF15 Plasma Level Is Inversely Associated With Level of Physical Activity and Correlates With Markers of Inflammation and Muscle Weakness , 2020, Frontiers in Immunology.

[15]  Alejandro Lucia,et al.  Chronic inflammation in the etiology of disease across the life span , 2019, Nature Medicine.

[16]  J. V. van Dalen,et al.  Visit-to-Visit Blood Pressure Variability and Progression of White Matter Hyperintensities Among Older People With Hypertension. , 2019, Journal of the American Medical Directors Association.

[17]  M. Pisani,et al.  GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance , 2019, Cell.

[18]  Sean K. Maden,et al.  Senescence‐associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15 , 2019, Aging cell.

[19]  C-C Lin,et al.  Visit-to-visit blood pressure variability and hip fracture risk in older persons , 2019, Osteoporosis International.

[20]  Shouling Wu,et al.  Blood Pressure Variability Is Associated with Hearing and Hearing Loss: A Population-Based Study in Males , 2019, International journal of hypertension.

[21]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[22]  P. Emmerson,et al.  GDF15 and Growth Control , 2018, Front. Physiol..

[23]  Kwang-il Kim,et al.  Relationship between Within-Visit Blood Pressure Variability and Skeletal Muscle Mass , 2018, The journal of nutrition, health & aging.

[24]  A. Donato,et al.  Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease , 2018, Circulation research.

[25]  S. Tarantini,et al.  Mechanisms of Vascular Aging. , 2018, Circulation research.

[26]  L. Ferrucci,et al.  A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup , 2018, GeroScience.

[27]  C. Franceschi,et al.  Inflammaging: a new immune–metabolic viewpoint for age-related diseases , 2018, Nature Reviews Endocrinology.

[28]  M. Fukui,et al.  Sarcopenia is associated with blood pressure variability in older patients with type 2 diabetes: A cross‐sectional study of the KAMOGAWA‐DM cohort study , 2018, Geriatrics & gerontology international.

[29]  Gianfranco Parati,et al.  Blood pressure variability: clinical relevance and application , 2018, Journal of clinical hypertension.

[30]  D. Mari,et al.  Human aging and longevity are characterized by high levels of mitokines. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  S. Laurent,et al.  Visit-to-visit blood pressure variability: added ‘VALUE’ as a risk marker in low- and high-risk patients , 2018, European heart journal.

[32]  Giuseppe Mancia,et al.  Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks , 2018, European heart journal.

[33]  G. Parati,et al.  Blood pressure variability and kidney disease: another vicious circle? , 2018, Journal of hypertension.

[34]  M. Silvestrini,et al.  Blood pressure variability and neurocognitive functioning , 2018, Journal of clinical hypertension.

[35]  H. Chung,et al.  GDF15 deficiency exacerbates chronic alcohol- and carbon tetrachloride-induced liver injury , 2017, Scientific Reports.

[36]  K. Joshipura,et al.  ASSOCIATION BETWEEN WITHIN-VISIT SYSTOLIC BLOOD PRESSURE VARIABILITY AND DEVELOPMENT OF PRE-DIABETES AND DIABETES AMONG OVERWEIGHT/OBESE INDIVIDUALS , 2017, Journal of Human Hypertension.

[37]  Francesco Paneni,et al.  The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels. , 2017, Journal of the American College of Cardiology.

[38]  J. Auwerx,et al.  Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis , 2017, The Journal of cell biology.

[39]  C. Burant,et al.  Frailty has a stronger association with inflammation than age in older veterans , 2016, Immunity & Ageing.

[40]  A. D. de Craen,et al.  Visit-to-visit blood pressure variability and future functional decline in old age , 2016, Journal of hypertension.

[41]  M. Irigoyen,et al.  Hypertension, Blood Pressure Variability, and Target Organ Lesion , 2016, Current Hypertension Reports.

[42]  Y. Fukumoto,et al.  Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders , 2015, Annals of neurology.

[43]  S. Banerjee,et al.  GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective , 2015, Journal of diabetes research.

[44]  N. Sattar,et al.  Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. , 2015, American journal of hypertension.

[45]  K. Iczkowski,et al.  Reduced expression of GDF‐15 is associated with atrophic inflammatory lesions of the prostate , 2015, The Prostate.

[46]  J. Blacher,et al.  Prognostic Significance of Visit‐to‐Visit Systolic Blood Pressure Variability: A Meta‐Analysis of 77,299 Patients , 2015, Journal of clinical hypertension.

[47]  J. Dartigues,et al.  Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study , 2014, Alzheimer's & Dementia.

[48]  M. Weiner,et al.  MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA. , 2014, The journal of prevention of Alzheimer's disease.

[49]  C. Reid,et al.  Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients , 2014, Journal of hypertension.

[50]  A. Reiner,et al.  Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[51]  B. Davis,et al.  Visit‐to‐Visit Blood Pressure Variability and Cardiovascular Death in the Systolic Hypertension in the Elderly Program , 2014, Journal of clinical hypertension.

[52]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[53]  Gianfranco Parati,et al.  Assessment and management of blood-pressure variability , 2013, Nature Reviews Cardiology.

[54]  H. Rakugi,et al.  The impact of visit-to-visit variability in blood pressure on renal function , 2012, Hypertension Research.

[55]  Siegfried Hekimi,et al.  Taking a "good" look at free radicals in the aging process. , 2011, Trends in cell biology.

[56]  P. Rothwell,et al.  Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension , 2010, The Lancet.

[57]  E. O’Brien,et al.  Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension , 2010, The Lancet.

[58]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[59]  M. Emdin,et al.  Awake Blood Pressure Variability, Inflammatory Markers and Target Organ Damage in Newly Diagnosed Hypertension , 2008, Hypertension Research.

[60]  Hyuk-Jae Chang,et al.  Association between blood pressure variability and inflammatory marker in hypertensive patients. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[61]  G. Pierce,et al.  Direct Evidence of Endothelial Oxidative Stress With Aging in Humans: Relation to Impaired Endothelium-Dependent Dilation and Upregulation of Nuclear Factor-&kgr;B , 2007, Circulation research.

[62]  V. Vaccarino,et al.  Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. , 2006, The American journal of cardiology.

[63]  J. Doyle,et al.  Bow Ties, Metabolism and Disease , 2022 .

[64]  M. Crabtree,et al.  Prevention and Reversal of Premature Endothelial Cell Senescence and Vasculopathy in Obesity-Induced Diabetes by Ebselen , 2004, Circulation research.

[65]  Y. Imai,et al.  Office blood pressure variability as a predictor of acute myocardial infarction in elderly patients receiving antihypertensive therapy , 2002, Journal of Human Hypertension.

[66]  Lenore J Launer,et al.  Variability in Midlife Systolic Blood Pressure Is Related to Late-Life Brain White Matter Lesions: The Honolulu-Asia Aging Study , 2002, Stroke.

[67]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[68]  G. Mancia,et al.  Alterations in neural cardiovascular control mechanisms with ageing. , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[69]  L. Ferrucci,et al.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. , 1994, Journal of gerontology.

[70]  A S Leon,et al.  A questionnaire for the assessment of leisure time physical activities. , 1978, Journal of chronic diseases.